These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
711 related articles for article (PubMed ID: 9393858)
21. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Herzog CR; Noh S; Lantry LE; Guan KL; You M Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910 [TBL] [Abstract][Full Text] [Related]
22. [Alternative protein p19ARF: a genuine tumor suppressor gene]. Larsen CJ Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293 [TBL] [Abstract][Full Text] [Related]
23. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Kurokawa K; Tanaka T; Kato J Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346 [TBL] [Abstract][Full Text] [Related]
24. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Munro J; Stott FJ; Vousden KH; Peters G; Parkinson EK Cancer Res; 1999 Jun; 59(11):2516-21. PubMed ID: 10363964 [TBL] [Abstract][Full Text] [Related]
25. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064 [TBL] [Abstract][Full Text] [Related]
26. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Gilley J; Fried M Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876 [TBL] [Abstract][Full Text] [Related]
27. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455 [TBL] [Abstract][Full Text] [Related]
28. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Sebastian T; Johnson PF Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382 [TBL] [Abstract][Full Text] [Related]
29. Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors. Tam AS; Devereux TR; Patel AC; Foley JF; Maronpot RR; Massey TE Carcinogenesis; 2003 Jan; 24(1):121-32. PubMed ID: 12538357 [TBL] [Abstract][Full Text] [Related]
30. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways. Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500 [TBL] [Abstract][Full Text] [Related]
31. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370 [TBL] [Abstract][Full Text] [Related]
32. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827 [TBL] [Abstract][Full Text] [Related]
33. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221 [TBL] [Abstract][Full Text] [Related]
34. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis. Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409 [TBL] [Abstract][Full Text] [Related]
35. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Orlow I; Rabbani F; Chin L; Pomerantz J; Ligeois N; Dudas M; Depinho R; Cordón-Cardó C Int J Oncol; 1999 Jul; 15(1):17-24. PubMed ID: 10375589 [TBL] [Abstract][Full Text] [Related]
36. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658 [TBL] [Abstract][Full Text] [Related]
37. Ubiquitination of, and sumoylation by, the Arf tumor suppressor. den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360 [TBL] [Abstract][Full Text] [Related]
38. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. Ivanchuk SM; Mondal S; Dirks PB; Rutka JT J Neurooncol; 2001 Feb; 51(3):219-29. PubMed ID: 11407594 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene. Schoppmeyer K; Norris PS; Haas M Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047 [TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]